Navigation Links
Systems biology recommended as a clinical approach to cancer
Date:7/9/2009

Blacksburg, Va. -- Four researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues at the Wake Forest University School of Medicine are advocating the use of systems biology as an innovative clinical approach to cancer. This approach could result in the development of improved diagnostic tools and treatment options, as well as potential new drug targets to help combat the many potentially fatal types of the disease.

In an upcoming paper* in Biochimica et Biophysica Acta, the international journal of biochemistry, biophysics and molecular biology, the team highlights the usefulness of a systems biology approach in developing a comprehensive view of cancer diseases, which will help researchers better understand the complex processes related to cancer progression, diagnosis, and treatment. Systems biology brings together mathematical modeling, simulations, and quantitative experiments, allowing researchers to use the data of one of the approaches to repeatedly define the framework of the other approaches. Biochemical networks are central to biological function, while computer models provide a particularly useful way to understand their workings. Biochemical models are the ideal means to design and predict the effect of interventions, such as cancer treatments.

"One of the goals of this paper is to show the potential benefits that can result from moving the use of systems biology techniques closer to the clinic," explained VBI Professor Reinhard Laubenbacher. "We believe this kind of shift is very possible. For example, mathematical models could integrate patient characteristics to help researchers determine the features of dynamic processes linked to cancer progression, diagnosis, and treatment. Systems biology has an increasingly important role in cancer research and treatment, especially as mathematical modelers, biologists, and clinicians continue working together. Through these transdisciplinary efforts, the needs of the clinic can directly impact work in the laboratory."

According to the researchers, before the functional differences between a cancer cell and a normal cell can be understood, an assessment of the overall biochemical network, not just the individual molecular mechanisms involved, is needed. A more complete picture of the system's dynamic characteristics can help contribute to the development of improved diagnostics and techniques that can disrupt the progression of the disease. They discuss three case studies related to diagnostics, therapy, and drug development in detail to demonstrate how a systems-level view can provide important insights related to the disease. The examples, which involve cases of breast cancer, B-cell lymphomas, and colorectal cancer, demonstrate the various kinds of clinical issues that can arise, as well as the use of different mathematical methods that can be used in a systems biology approach.

According to Wake Forest University Professor of Medicine Steve Akman, "The systems biology approach provides an opportunity for major advancements in our understanding of carcinogenesis. Cancer biologists are just beginning to understand what mathematicians, engineers, and computer scientists have long known that the behavior of dynamic systems are more than just the sum of the individual components. The VBI-Wake Forest collaborative group was established in response to the realization that the potential applications of systems biology to the cancer problem will be effected only through collaborations between cancer biologists, mathematicians, engineers, and computer scientists."


'/>"/>

Contact: Susan Bland
subland@vbi.vt.edu
540-231-7912
Virginia Tech
Source:Eurekalert

Related biology news :

1. Systems Biology poised to revolutionize the understanding of cell function and disease
2. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
3. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
4. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
5. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
6. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
7. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
8. Smartcard Finger-Match Add-on for VeriFinger and MegaMatcher is Now Available for the Implementation of Biometric Fingerprint-on-Smartcard Verification Systems
9. Study shows genetically engineered corn could affect aquatic ecosystems
10. Genetically engineered corn may harm stream ecosystems
11. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
Breaking Biology News(10 mins):
(Date:7/25/2017)... ... July 25, 2017 , ... Fiberstar, Inc ., a global market ... Citri-Fi® 125. This natural citrus fiber is used to improve tomato-based food products by ... sauces, condiments and spreads. Today, more than ever, consumers connect ingredients to the foods ...
(Date:7/24/2017)... ... ... Charm Sciences, Inc. is pleased to announce the Charm® ROSA® Tetracycline-SL (Dilution ... (NCIMS) Laboratory Committee and Appendix N Committee as a drug residue test kit for ... voted at its annual meeting in April, 2015 to establish a pilot program to ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... the stock market news outlet had initiated coverage on Interpace Diagnostics. Interpace ... and identifies exposure, progression and risk analysis from specific cancers in humans. ...
(Date:7/20/2017)... ... 20, 2017 , ... Dr. Asher Kimchi, Founder and Chairman of the ... Awards at the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. ... the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. ...
Breaking Biology Technology: